Simulations Plus (SLP)
(Delayed Data from NSDQ)
$36.83 USD
+0.35 (0.96%)
Updated Aug 23, 2024 03:59 PM ET
After-Market: $36.82 -0.01 (-0.03%) 7:58 PM ET
4-Sell of 5 4
F Value F Growth B Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$36.83 USD
+0.35 (0.96%)
Updated Aug 23, 2024 03:59 PM ET
After-Market: $36.82 -0.01 (-0.03%) 7:58 PM ET
4-Sell of 5 4
F Value F Growth B Momentum F VGM
Zacks News
Implied Volatility Surging for Simulations Plus (SLP) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Simulations Plus (SLP) stock based on the movements in the options market lately.
Simulations Plus (SLP) Ties Up With ICCS for Chemical Safety
by Zacks Equity Research
Simulations Plus (SLP) announces a collaboration with ICCS on a research initiative to advance animal-free safety assessment of new chemicals
Simulations Plus (SLP) Q3 Earnings & Revenues Beat Estimates
by Zacks Equity Research
Simulations Plus' (SLP) fiscal third-quarter revenues are driven by strength in Software and Services units.
Analysts Estimate Simulations Plus (SLP) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Simulations Plus (SLP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Manhattan Associates (MANH) Soars 3.0%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Manhattan Associates (MANH) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Simulations Plus (SLP) Upgraded to Buy: Here's Why
by Zacks Equity Research
Simulations Plus (SLP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Adobe Systems (ADBE) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Adobe (ADBE) delivered earnings and revenue surprises of 2.05% and 0.54%, respectively, for the quarter ended May 2024. Do the numbers hold clues to what lies ahead for the stock?
Simulations Plus (SLP) Buys Pro-ficiency Holdings for $100M
by Zacks Equity Research
Simulation Plus (SLP) acquires Pro-ficiency from QHP Capital for $100 million in an all-cash transaction.
Broadcom Inc. (AVGO) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Broadcom Inc. (AVGO) delivered earnings and revenue surprises of 1.58% and 3.71%, respectively, for the quarter ended April 2024. Do the numbers hold clues to what lies ahead for the stock?
Autodesk (ADSK) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Autodesk (ADSK) delivered earnings and revenue surprises of 5.06% and 1.46%, respectively, for the quarter ended April 2024. Do the numbers hold clues to what lies ahead for the stock?
American Software (AMSWA) Surpasses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
American Software (AMSWA) delivered earnings and revenue surprises of 50% and 2.08%, respectively, for the quarter ended April 2024. Do the numbers hold clues to what lies ahead for the stock?
Simulations Plus (SLP) Launches GPX to Advance PBPK Modeling
by Zacks Equity Research
Simulations Plus (SLP) unveils GastroPlus X, which significantly reduces time spent on model setup, data management, and reformatting results.
Simulations Plus (SLP) DILIsym Software Licenses Renewed by FDA
by Zacks Equity Research
For the seventh consecutive year, the FDA has renewed Simulations Plus' (SLP) license to the DILIsym software system for facilitating drug safety evaluations.
Simulations Plus (SLP) Q2 Earnings & Revenues Beat Estimates
by Zacks Equity Research
Simulations Plus' (SLP) second-quarter fiscal 2024 top line is driven by higher revenues in the Software and Services business segments.
Simulations Plus (SLP) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Simulations Plus (SLP) delivered earnings and revenue surprises of 11.11% and 7.24%, respectively, for the quarter ended February 2024. Do the numbers hold clues to what lies ahead for the stock?
Simulations Plus (SLP) to Report Q2 Earnings: What's in Store?
by Zacks Equity Research
Simulations Plus (SLP) fiscal second-quarter performance is likely to have benefited from momentum across Software and Services business segments.
Adobe Systems (ADBE) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Adobe (ADBE) delivered earnings and revenue surprises of 2.28% and 0.94%, respectively, for the quarter ended February 2024. Do the numbers hold clues to what lies ahead for the stock?
Down -5.35% in 4 Weeks, Here's Why You Should You Buy the Dip in Simulations Plus (SLP)
by Zacks Equity Research
Simulations Plus (SLP) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Bears are Losing Control Over Simulations Plus (SLP), Here's Why It's a 'Buy' Now
by Zacks Equity Research
Simulations Plus (SLP) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
3 Stocks in Focus on the Power of New Analyst Coverage
by Shrabana Mukherjee
The recent surge in analyst coverage for stocks such as Simulations (SLP), Centrus (LEU) and Green Brick (GRBK) indicates the potential for significant price appreciation in the near term.
Simulations Plus (SLP) Q1 Earnings Miss, Revenues Rise Y/Y
by Zacks Equity Research
Simulations Plus' (SLP) first-quarter fiscal 2024 top line is driven by higher revenues in the Software and Services business segments amid relatively soft client funding and budget cycles.
Simulations Plus (SLP) to Report Q1 Earnings: What's in Store?
by Zacks Equity Research
Simulations Plus (SLP) fiscal first-quarter performance is likely to have benefited from momentum across Software and Services business segments.
Adobe Systems (ADBE) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
Adobe (ADBE) delivered earnings and revenue surprises of 3.39% and 0.82%, respectively, for the quarter ended November 2023. Do the numbers hold clues to what lies ahead for the stock?
Oracle (ORCL) Q2 Earnings Top Estimates
by Zacks Equity Research
Oracle (ORCL) delivered earnings and revenue surprises of 1.52% and 0.84%, respectively, for the quarter ended November 2023. Do the numbers hold clues to what lies ahead for the stock?
Hello Group Inc. Sponsored ADR (MOMO) Matches Q3 Earnings Estimates
by Zacks Equity Research
Hello Group Inc. Sponsored ADR (MOMO) delivered earnings and revenue surprises of 0% and 0.38%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?